Physician s Checklist for an IND Application for Emergency Treatment Emergency IND Sponsor s name and contact: Page 1 of 2 After the telephone call to FDA, record information here IND Application.
Open form follow the instructions
Easily sign the form with your finger
Send filled & signed form or save
How to fill out the Physician's Checklist For An IND Application For Emergency Treatment - FDA online
This guide aims to assist users in completing the Physician's Checklist for an IND Application for Emergency Treatment at the FDA. Whether you are a treating physician or an IND application sponsor, this step-by-step walkthrough will help you navigate the online form effectively.
Follow the steps to complete the checklist online smoothly.
- Press the ‘Get Form’ button to access the checklist form and open it in your online document management system.
- In the first section, enter the Emergency IND sponsor’s name and contact information. This will be recorded after your initial communication with the FDA.
- Provide the IND application number assigned by the FDA and the date of contact in the designated fields.
- Fill in the FDA contact name, division, and phone number for reference.
- In the sponsor information section, enter the details of the treating physician, including their name, affiliation, phone, fax, address, and email. If applicable, also include the sponsor of the emergency IND application.
- Carefully review and ensure that all criteria for the emergency IND application are met. Provide justification for why the treatment is medically necessary in the patient's case.
- Complete the drug supply reference statement, including information about the IND supplier and whether they have agreed to provide the drug.
- Document the investigator's qualifications, including training, experience, and whether a CV has been attached.
- Fill out the patient’s information, including ID, gender, date of birth, weight, race, diagnosis, and disease status. Include additional information about previous therapies and responses.
- Outline the proposed treatment plan, including any relevant references, rationale, patient monitoring procedures, and modifications for toxicity.
- Ensure informed consent is obtained, documenting the signature and date, and note notifications regarding IRB within the required timeframe.
- Finally, review all sections for completeness and accuracy before submitting the form.
- Once you have filled out the checklist, you can save your changes, download the form, print it, or share it as needed.
Start completing your Physician's Checklist for an IND Application for Emergency Treatment online today.
Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Related content
diagnose, monitor, or treat the patient's condition. EAP. Treatment. Trial ... follow the...
Sep 27, 2017 — Prepared by NYU School of Medicine Institutional Review Board (IRB)...
The Office reserves the right to review protocols, delivery of services and ... The...
Get answers to your most pressing questions about US Legal Forms API.
What is emergency IND application?
Obtaining an Emergency IND The need for an investigational drug or biologic may arise in an emergency situation that does not allow time for submission of an IND. In such a case, FDA may authorize shipment of the test article in advance of the IND submission.
What documents are needed for IND?
Filing an IND requires completion of 3 sets of forms: 1 detailing the study (FDA Form 1571), 1 providing information about the investigator and study site (FDA Form 1572), and 1 certifying that the study is registered in the national database of clinical trials (FDA Form 3674).
What must be included in an IND application to FDA?
The IND application must contain information in three broad areas: Animal Pharmacology and Toxicology Studies - Preclinical data to permit an assessment as to whether the product is reasonably safe for initial testing in humans. Also included are any previous experience with the drug in humans (often foreign use).
What should be submitted to FDA as amendments to an IND?
Addition of a new investigator The amendment should include the investigator's name, the qualifications to conduct the investigation, and any reference to the previously submitted protocol, if relevant. The FDA should be notified within 30 days of the investigator being added.
What is the first thing a physician must do to get single patient expanded access to an investigational drug?
IRB approval and informed consent must be obtained before treatment begins. If the treatment use is not allowed to proceed (i.e., a clinical hold is placed on the application), FDA will notify the physician of this decision initially via a telephone call.
What is required for IND submission?
Filing an IND requires completion of 3 sets of forms: 1 detailing the study (FDA Form 1571), 1 providing information about the investigator and study site (FDA Form 1572), and 1 certifying that the study is registered in the national database of clinical trials (FDA Form 3674).
What are the components of new drug application?
An NDA for a new chemical entity will generally contain an application form, an index, a summary, five or six technical sections, case report tabulations of patient data, case report forms, drug samples, and labeling, including, if applicable, any Medication Guide required under part 208 of this chapter.
What comes under investigational new drug application?
An Investigational New Drug Application (IND) is a request from a clinical study sponsor to obtain authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans.
Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
If you believe that this page should be taken down, please follow our DMCA take down process here.